INTRODUCTION
Radiotherapy is an effective treatment for head and neck cancers but it may also cause long-term damages to the carotid arteries, resulting in arterial stenosis, occlusion or the formation of pseudoaneurysms.(1) Post-irradiated carotid pseudoaneurysms after radiotherapy for nasopharyngeal cancer typically occur at the petrous and laceral carotid artery, and may present with life-threatening epistaxis due to carotid blowout syndrome (CBS).(2) Recognized treatments for these lesions include parent artery occlusion (PVO) with or without revascularization, endovascular coil embolization, and covered stenting. (3, 4) The introduction of endovascular flow-diverters provides another potential treatment option. The pipeline embolization device (PED) is one of these flow-diverters with 30-35% surface coverage, designed to achieve curative reconstruction of intracranial arteries that harbor aneurysms with challenging morphologies. (5, 6) Outcome in the treatment of non-ruptured intracranial aneurysms was satisfactory.(7-10) However, its efficacy for ruptured pseudoaneurysm, in particular that with an extradural location at the skull base is unclear. We present our experience with the PED in the treatment of patients with ruptured post-irradiated ICA pseudoaneurysms at the skull base.
PATIENTS AND METHODS

Patients
This is a retrospective study of prospectively collected data of all-inclusive patients treated with the PED for radiation-induced extracranial ICA pseudoaneurysms at our institution from April 2011 to March 2013. All patients had history of nasopharyngeal carcinoma primarily treated with prior external radiotherapy involving the skull base, and had developed ICA pseudoaneurysms within the irradiated fields at the skull base. All presented with severe epistaxis due to aneurysm rupture. Initial hemostasis was achieved by means of nasal packing, followed by diagnostic digital subtraction angiography (DSA) and PED reconstruction on an emergency basis within 24 hours. 
Procedure and Follow-up
Immediately before PED placement, patients were given 300mg of clopidogrel and 300 mg of aspirin. Clopidogrel (75mg daily) was maintained for at least one week and aspirin (80mg daily) was given for six months after surgery. Low molecular weight heparin was given at 1mg/kg every 12 hours and was maintained for 24 hours after surgery. Intravenous prophylactic antibiotics (amoxicillin-clavulanate 1.2g and metronidazole 500mg) were given on induction of general anesthesia, and maintained for one week post-operatively.
The PED (ev3 Inc, Plymouth, MN, USA) was deployed in the standard manner using transfermoral arterial approach. Additional PEDs were placed telescopically with the overlapping segment covering the entire aneurysm neck for double coverage if there was inadequate contrast stasis in the aneurysm sac. (Figure 3b ) Coils were deployed prior to placement of PED when there was ongoing contrast extravasation or the aneurysm sac was large to facilitate hemostasis and thrombosis of pseudoaneurysm. (Figure 2b ) A check DSA was performed to ensure that the entire aneurysm neck was covered, and to exclude acute in-stent thrombosis, distal embolism and contrast extravasation through the aneurysm.
Outcome assessment
We assessed the efficacy of immediate and mid-term hemostasis, and the occurrence of periprocedural complications including ischemic and hemorrhagic neurological events. Follow-up DSA or computer tomography (CT) angiograms were performed to assess aneurysm obliteration, delayed in-stent stenosis and device migration. Patients' neurologic outcomes were assessed using the modified Rankin's Score. The patient who had a contralateral pseudoaneurysm treated previously (Patient 2) suffered from ischemic cerebral infarctions after PED placement at our center. There was left ICA occlusion, presumably due to previous treatment at another center, as well as 70% right common carotid artery and 50% right proximal ICA stenosis. We performed right ICA angioplasty and stenting for the stenosis prior to PED placement. This patient developed multiple ischemic infarctions afterwards which were likely secondary to endovascular manipulations within a precarious circulation. (Figure 1 ) There was no other peri-procedural complication.
RESULTS
Patient
Follow-up angiographic studies were performed in five patients. A single PED has 30 to 35% surface area coverage. To secure the pseudoaneurysm and prevent re-rupture, we deliberately used multiple PEDs in 6 of the patients with telescopic placement in an attempt to increase coverage over the aneurysm neck. We also used adjuvant coiling when there was ongoing contrast extravasation or when the aneurysm sac was large. This was necessary in two of our seven patients. This approach was similar to the successful experience by carotid artery and multifocal stenosis of the right carotid artery due to previous radiation. In order to secure the pseudoaneurysm, we had to perform angioplasty and negotiate through the proximal stenosed carotid artery before deploying the PED. He suffered from peri-procedural infarct. In addition, 3 patients developed delayed stent thrombosis, of which 1 was symptomatic.
Symptomatic infarctions secondary to delayed in-stent thrombosis similar to Patient 6 have been reported. (6, 35) . Patient 6 was put on double anti-platelet agents since PED placement, clopidogrel was stopped 2 weeks later and aspirin maintained for 6 months. This patient remained asymptomatic for 4 months after cessation of all anti-platelet therapy, and only developed lacunar infarct with in-construct thrombosis at 10 months after initial PED placement.
We surmise this worrisome rate of ischemic complications may be due to the inadequate antiplatelet regimen we used in this particular group of patients, compounded with delayed endothelialization of irradiated parent arteries as well as use of multiple PEDs. The optimal duration for antiplatelet treatment after flow diverters is unclear. For elective treatment of unruptured aneurysms, we routinely prescribe double antiplatelet agents for at least 3 months followed by aspirin for 6 months in total. However, in the present study, the patients were constantly at risk of life-threatening bleeding from the pseudoaneurysm, the osteonecrotic nasopharynx or recurrent nasopharyngeal tumor. We therefore were much more prudent with antiplatelet agents and only used double antiplatelet agents for the initial 1-4 weeks followed by aspirin alone subsequently. Although we did not encounter hemorrhagic complications, this overcautious antiplatelet regimen led to a high ischemic risk. The high delayed in-stent thrombosis rate demonstrated in our series highlighted the importance of adequate antiplatelet treatment. In light of the significant ischemic risk, long term or even life-long antiplatelet agents may be indicated after PED placement, in particular in irradiated arteries, although the hemorrhagic risk remains a concern. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
